Paper20177667
Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells.
Faouzi M and 3 others. J Membr Biol, 2010. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells. Papers, record 20177667. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20177667
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Intermediate-Conductance Calcium-Activated Potassium Channels | Major topic |
| Janus Kinase 2 | Major topic |
| Receptors, Prolactin | Major topic |
| Breast Neoplasms | |
| Calcium | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Clotrimazole | |
| Female | |
| Humans | |
| Prolactin | |
| Pyrazoles | |
| Tyrphostins |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16489055 | Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. | Cancer Res | 2006 | https://conductscience.org/library/papers/16489055 | PubMed |
| 2 | 11572805 | Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. | J Endocrinol | 2001 | https://conductscience.org/library/papers/11572805 | PubMed |
| 3 | 11923474 | PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. | Mol Endocrinol | 2002 | https://conductscience.org/library/papers/11923474 | PubMed |
| 4 | 14586031 | Effects of prolactin on ionic membrane conductances in the human malignant astrocytoma cell line U87-MG. | J Neurophysiol | 2004 | https://conductscience.org/library/papers/14586031 | PubMed |
| 5 | 8663214 | Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8663214 | PubMed |
| 6 | 11032019 | Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. | Oncogene | 2000 | https://conductscience.org/library/papers/11032019 | PubMed |
| 7 | 9723866 | Prolactin induces an inward current through voltage-independent Ca2+ channels in Chinese hamster ovary cells stably expressing prolactin receptor. | J Mol Endocrinol | 1998 | https://conductscience.org/library/papers/9723866 | PubMed |
| 8 | 14985237 | Functional and molecular identification of intermediate-conductance Ca(2+)-activated K(+) channels in breast cancer cells: association with cell cycle progression. | Am J Physiol Cell Physiol | 2004 | https://conductscience.org/library/papers/14985237 | PubMed |
| 9 | 12826234 | Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. | Eur J Pharmacol | 2003 | https://conductscience.org/library/papers/12826234 | PubMed |
| 10 | 18246319 | Prolactin and breast cancer etiology: an epidemiologic perspective. | J Mammary Gland Biol Neoplasia | 2008 | https://conductscience.org/library/papers/18246319 | PubMed |
| 11 | 14978241 | Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. | Mol Pharmacol | 2004 | https://conductscience.org/library/papers/14978241 | PubMed |
| 12 | 9774475 | Distinct cytoplasmic regions of the prolactin receptor are required for prolactin-induced calcium entry. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9774475 | PubMed |
| 13 | 12588805 | The role of prolactin in mammary carcinoma. | Endocr Rev | 2003 | https://conductscience.org/library/papers/12588805 | PubMed |
| 14 | 12825859 | Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth. | Breast Cancer Res Treat | 2003 | https://conductscience.org/library/papers/12825859 | PubMed |
| 15 | 18060344 | K+ channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. | J Membr Biol | 2008 | https://conductscience.org/library/papers/18060344 | PubMed |
| 16 | 14565846 | Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation. | Biochem J | 2004 | https://conductscience.org/library/papers/14565846 | PubMed |
| 17 | 11968058 | Effects of prolactin on intracellular calcium concentration and cell proliferation in human glioma cells. | Glia | 2002 | https://conductscience.org/library/papers/11968058 | PubMed |
| 18 | 19153125 | Re-evaluation of the prolactin receptor expression in human breast cancer. | J Endocrinol | 2009 | https://conductscience.org/library/papers/19153125 | PubMed |
| 19 | 1718958 | A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1718958 | PubMed |
| 20 | 7534043 | Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. | Am J Pathol | 1995 | https://conductscience.org/library/papers/7534043 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33521321 | Targeting the JAK/STAT pathway in solid tumors. | J Cancer Metastasis Treat | 2020 | https://conductscience.org/library/papers/33521321 | PubMed |
| 28557306 | SK4 channels modulate Ca2+ signalling and cell cycle progression in murine breast cancer. | Mol Oncol | 2017 | https://conductscience.org/library/papers/28557306 | PubMed |
| 28530221 | MICU1 drives glycolysis and chemoresistance in ovarian cancer. | Nat Commun | 2017 | https://conductscience.org/library/papers/28530221 | PubMed |
| 28280257 | Intermediate-Conductance-Ca2-Activated K Channel IKCa1 Is Upregulated and Promotes Cell Proliferation in Cervical Cancer | Med Sci Monit Basic Res | 2017 | https://conductscience.org/library/papers/28280257 | PubMed |
| 27814637 | Zinc transporters and dysregulated channels in cancers. | Front Biosci (Landmark Ed) | 2017 | https://conductscience.org/library/papers/27814637 | PubMed |
| 27531900 | miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27531900 | PubMed |
| 27183905 | Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis. | Oncotarget | 2016 | https://conductscience.org/library/papers/27183905 | PubMed |
| 27069638 | Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells. | Pharmacol Res Perspect | 2016 | https://conductscience.org/library/papers/27069638 | PubMed |
| 26350345 | X-ray irradiation activates K+ channels via H2O2 signaling. | Sci Rep | 2015 | https://conductscience.org/library/papers/26350345 | PubMed |
| 24336491 | The roles of K(+) channels in cancer. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/24336491 | PubMed |
| 24116006 | Altered expression of two-pore domain potassium (K2P) channels in cancer. | PLoS One | 2013 | https://conductscience.org/library/papers/24116006 | PubMed |
| 23970866 | K(+) channels and cell cycle progression in tumor cells. | Front Physiol | 2013 | https://conductscience.org/library/papers/23970866 | PubMed |
| 21851427 | Prolactin induces a hyperpolarising current in rat paraventricular oxytocinergic neurones. | J Neuroendocrinol | 2011 | https://conductscience.org/library/papers/21851427 | PubMed |
| 21123738 | Calcium-activated K+ channels increase cell proliferation independent of K+ conductance. | Am J Physiol Cell Physiol | 2011 | https://conductscience.org/library/papers/21123738 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
| KCNN4 | 3783 | PubTator's text mining | https://conductscience.org/library/genes/3783 | NCBI Gene |
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
| PRLR | 5618 | PubTator's text mining | https://conductscience.org/library/genes/5618 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20177667
GET https://conductscience.org/api/papers/v1/20177667/references?page=2